Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and safety of Elbasvir/Grazoprevir in women infected with hepatitis C virus genotype 1 or 4 and co-administered oral contraceptives or hormone replacement therapy Hezode, C., Kwo, P., Sperl, J., Dore, G., Hwang, P., Long, J., Talwani, R., Robertson, M., Haber, B. ELSEVIER SCIENCE BV. 2018: S264–S265
View details for Web of Science ID 000461068601134